News
Print PDF

Practice Areas

DEA to Restrict Imports and Exports of Synthetic Cannabinoids

Thursday, May 31, 2018
Sandler, Travis & Rosenberg Trade Report

The Drug Enforcement Administration has announced its intent to issue an order temporarily including the following synthetic cannabinoids into schedule I of the Controlled Substances Act.

- naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (trivial name: NM2201; CBL2201)

- N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1Hindazole-3-carboxamide (trivial name: 5F-AB-PINACA)

- 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (trivial name: 4-CN-CUMYLBUTINACA; 4-cyano-CUMYL-BUTINACA; 4-CN-CUMYL BINACA; CUMYL-4CNBINACA; SGT-78)

- methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate (trivial names: MMB-CHMICA, AMB-CHMICA)

- 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide (trivial name: 5F-CUMYL-P7AICA)

The temporary scheduling order will impose the administrative, civil, and criminal sanctions and regulatory controls applicable to schedule I substances under the CSA on the importation, exportation, manufacture, distribution, reverse distribution, possession, research and conduct of instructional activities, and chemical analysis of these substances. It will be effective no earlier than June 29 and remain in effect for two years, with a possible extension of one year.

To get news like this in your inbox daily, subscribe to the Sandler, Travis & Rosenberg Trade Report.

Customs & International Headlines